Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Video-assisted thoracic lobectomy versus stereotactic body radiotherapy for stage I nonsmall cell lung cancer in elderly patients: a propensity matched comparative analysis.

Detillon DDEMA, Aarts MJ, De Jaeger K, Van Eijck CHJ, Veen EJ.

Eur Respir J. 2019 Jun 20;53(6). pii: 1801561. doi: 10.1183/13993003.01561-2018. Print 2019 Jun.

PMID:
30923188
2.

Inter-observer variation of hippocampus delineation in hippocampal avoidance prophylactic cranial irradiation.

Bartel F, van Herk M, Vrenken H, Vandaele F, Sunaert S, de Jaeger K, Dollekamp NJ, Carbaat C, Lamers E, Dieleman EMT, Lievens Y, de Ruysscher D, Schagen SB, de Ruiter MB, de Munck JC, Belderbos J.

Clin Transl Oncol. 2019 Feb;21(2):178-186. doi: 10.1007/s12094-018-1903-7. Epub 2018 Jun 6.

PMID:
29876759
3.

Impact of brachytherapy technique (2D versus 3D) on outcome following radiotherapy of cervical cancer.

Derks K, Steenhuijsen JLG, van den Berg HA, Houterman S, Cnossen J, van Haaren P, De Jaeger K.

J Contemp Brachytherapy. 2018 Feb;10(1):17-25. doi: 10.5114/jcb.2018.73955. Epub 2018 Feb 22.

4.

Interobserver variability in the delineation of the primary lung cancer and lymph nodes on different four-dimensional computed tomography reconstructions.

Mercieca S, Belderbos JSA, De Jaeger K, Schinagl DAX, van der Voort Van Zijp N, Pomp J, Theuws J, Khalifa J, van de Vaart P, van Herk M.

Radiother Oncol. 2018 Feb;126(2):325-332. doi: 10.1016/j.radonc.2017.11.020. Epub 2017 Dec 5.

PMID:
29208512
5.

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial.

Louie AV, van Werkhoven E, Chen H, Smit EF, Paul MA, Widder J, Groen HJ, van den Borne BE, De Jaeger K, Slotman BJ, Senan S.

Radiother Oncol. 2015 Oct;117(1):44-8. doi: 10.1016/j.radonc.2015.08.011.

PMID:
26492839
6.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Chang JY, Senan S, Paul MA, Mehran RJ, Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, van den Borne BE, Munsell MF, Hurkmans C, Berry DA, van Werkhoven E, Kresl JJ, Dingemans AM, Dawood O, Haasbeek CJ, Carpenter LS, De Jaeger K, Komaki R, Slotman BJ, Smit EF, Roth JA.

Lancet Oncol. 2015 Jun;16(6):630-7. doi: 10.1016/S1470-2045(15)70168-3. Epub 2015 May 13. Erratum in: Lancet Oncol. 2015 Sep;16(9):e427.

7.

Patient selection for whole brain radiotherapy (WBRT) in a large lung cancer cohort: Impact of a new Dutch guideline on brain metastases.

Hendriks LE, Troost EG, Steward A, Bootsma GP, De Jaeger K, van den Borne BE, Dingemans AM.

Acta Oncol. 2014 Jul;53(7):945-51. doi: 10.3109/0284186X.2014.906746. Epub 2014 Apr 23.

PMID:
24754845
8.

Dose painting by contours versus dose painting by numbers for stage II/III lung cancer: practical implications of using a broad or sharp brush.

Meijer G, Steenhuijsen J, Bal M, De Jaeger K, Schuring D, Theuws J.

Radiother Oncol. 2011 Sep;100(3):396-401. doi: 10.1016/j.radonc.2011.08.048. Epub 2011 Sep 28.

PMID:
21955663
9.

Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy.

Haasbeek CJ, Lagerwaard FJ, de Jaeger K, Slotman BJ, Senan S.

Cancer. 2009 Feb 1;115(3):587-94. doi: 10.1002/cncr.24068.

10.

Evaluation of a single-isocenter technique for axillary radiotherapy in breast cancer.

van Beek S, De Jaeger K, Mijnheer B, van Vliet-Vroegindeweij C.

Med Dosim. 2008 Autumn;33(3):191-8. doi: 10.1016/j.meddos.2007.06.003.

PMID:
18674683
11.

Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy.

Belderbos JS, Heemsbergen WD, De Jaeger K, Baas P, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):126-34.

PMID:
16904518
12.

Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation.

Steenbakkers RJ, Duppen JC, Fitton I, Deurloo KE, Zijp L, Uitterhoeve AL, Rodrigus PT, Kramer GW, Bussink J, De Jaeger K, Belderbos JS, Hart AA, Nowak PJ, van Herk M, Rasch CR.

Radiother Oncol. 2005 Nov;77(2):182-90. Epub 2005 Oct 26.

PMID:
16256231
13.

Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis.

Steenbakkers RJ, Duppen JC, Fitton I, Deurloo KE, Zijp LJ, Comans EF, Uitterhoeve AL, Rodrigus PT, Kramer GW, Bussink J, De Jaeger K, Belderbos JS, Nowak PJ, van Herk M, Rasch CR.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):435-48. Epub 2005 Sep 28.

PMID:
16198064
14.

In response to Drs. Anscher and Kong.

De Jaeger K, Seppenwoolde Y, Lebesque JV, Kampinga HH.

Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):308. No abstract available.

PMID:
16111602
15.

Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.

Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV.

Eur J Cancer. 2005 Jul;41(11):1533-41.

PMID:
15953716
16.

Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.

Borst GR, De Jaeger K, Belderbos JS, Burgers SA, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):639-44.

PMID:
15936539
17.

Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.

Seppenwoolde Y, De Jaeger K, Boersma LJ, Belderbos JS, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):748-58.

PMID:
15465191
18.

Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.

De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma LJ, Belderbos JS, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1378-87.

PMID:
15050313
19.

Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue.

De Jaeger K, Hoogeman MS, Engelsman M, Seppenwoolde Y, Damen EM, Mijnheer BJ, Boersma LJ, Lebesque JV.

Radiother Oncol. 2003 Oct;69(1):1-10.

PMID:
14597351
20.

In regard to Tsujino et al.: predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. IJROBP 2003;55:110-115.

Seppenwoolde Y, De Jaeger K, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1208-9; author reply 1209. No abstract available.

PMID:
12829167
21.

Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.

De Jaeger K, Seppenwoolde Y, Boersma LJ, Muller SH, Baas P, Belderbos JS, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1331-40.

PMID:
12654445
22.

First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy.

Belderbos JS, De Jaeger K, Heemsbergen WD, Seppenwoolde Y, Baas P, Boersma LJ, Lebesque JV.

Radiother Oncol. 2003 Feb;66(2):119-26.

PMID:
12648783
23.

Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.

Seppenwoolde Y, Lebesque JV, de Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, Henning GT, Hayman JA, Martel MK, Ten Haken RK.

Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):724-35.

PMID:
12573760
24.

Portal imaging to assess set-up errors, tumor motion and tumor shrinkage during conformal radiotherapy of non-small cell lung cancer.

Erridge SC, Seppenwoolde Y, Muller SH, van Herk M, De Jaeger K, Belderbos JS, Boersma LJ, Lebesque JV.

Radiother Oncol. 2003 Jan;66(1):75-85.

PMID:
12559524
25.

Optimizing radiation treatment plans for lung cancer using lung perfusion information.

Seppenwoolde Y, Engelsman M, De Jaeger K, Muller SH, Baas P, McShan DL, Fraass BA, Kessler ML, Belderbos JS, Boersma LJ, Lebesque JV.

Radiother Oncol. 2002 May;63(2):165-77.

PMID:
12063006
26.

pH, hypoxia and metastasis.

Hill RP, De Jaeger K, Jang A, Cairns R.

Novartis Found Symp. 2001;240:154-65; discussion 165-8. Review.

PMID:
11727927
27.

The effect of breathing and set-up errors on the cumulative dose to a lung tumor.

Engelsman M, Damen EM, De Jaeger K, van Ingen KM, Mijnheer BJ.

Radiother Oncol. 2001 Jul;60(1):95-105.

PMID:
11410310
28.

Relationship of hypoxia to metastatic ability in rodent tumours.

De Jaeger K, Kavanagh MC, Hill RP.

Br J Cancer. 2001 May 4;84(9):1280-5.

29.

Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis.

De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, Hill RP.

Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):717-21.

PMID:
9845083
30.

Supplemental Content

Loading ...
Support Center